Recent events surrounding a cannabis genomics company in Oregon have sparked outrage amongst the cannabis community. This particular organization offered sequencing services claiming it would serve as a mechanism for demonstrating prior art to combat future patents. Instead, those services were used to stock a breeding program that would directly compete with the very same cultivators who purchased their services. …